Open Access
Enhanced Immunotherapeutic Efficacy of Anti–PD-L1 Antibody in Combination with an EP4 Antagonist
Yamato Sajiki, Satoru Konnai, Zimeng Cai, Kensuke Takada, Tomohiro Okagawa, Naoya Maekawa, Sotaro Fujisawa, Yukinari Kato, Yasuhiko Suzuki, Shiro Murata and Kazuhiko Ohashi
ImmunoHorizons December 1, 2020, 4 (12) 837-850; DOI: https://doi.org/10.4049/immunohorizons.2000089